These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25022850)

  • 1. Successful use of rituximab in the treatment of childhood and juvenile pemphigus.
    Vinay K; Kanwar AJ; Sawatkar GU; Dogra S; Ishii N; Hashimoto T
    J Am Acad Dermatol; 2014 Oct; 71(4):669-75. PubMed ID: 25022850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of rituximab treatment in Indian pemphigus patients.
    Kanwar AJ; Tsuruta D; Vinay K; Koga H; Ishii N; Dainichi T; Hashimoto T
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e17-23. PubMed ID: 22176540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus.
    Londhe PJ; Kalyanpad Y; Khopkar US
    Indian J Dermatol Venereol Leprol; 2014; 80(4):300-5. PubMed ID: 25035353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
    Cianchini G; Lupi F; Masini C; Corona R; Puddu P; De Pità O
    J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities.
    Cho HH; Jin SP; Chung JH
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):186-91. PubMed ID: 23356542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients.
    Leshem YA; Hodak E; David M; Anhalt GJ; Mimouni D
    J Am Acad Dermatol; 2013 Mar; 68(3):404-11. PubMed ID: 23044076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durable remission of pemphigus with a fixed-dose rituximab protocol.
    Heelan K; Al-Mohammedi F; Smith MJ; Knowles S; Lansang P; Walsh S; Shear NH
    JAMA Dermatol; 2014 Jul; 150(7):703-8. PubMed ID: 24500264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.
    Reguiai Z; Tabary T; Maizières M; Bernard P
    J Am Acad Dermatol; 2012 Oct; 67(4):623-9. PubMed ID: 22261417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
    Matsukura S; Knowles SR; Walsh S; Shear NH
    Arch Dermatol; 2012 Jun; 148(6):734-9. PubMed ID: 22351790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose rituximab is effective in pemphigus.
    Horváth B; Huizinga J; Pas HH; Mulder AB; Jonkman MF
    Br J Dermatol; 2012 Feb; 166(2):405-12. PubMed ID: 21967609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.
    Fuertes I; Guilabert A; Mascaró JM; Iranzo P
    Dermatology; 2010 Aug; 221(1):13-6. PubMed ID: 20389028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab): five cases.
    Antonucci A; Negosanti M; Tabanelli M; Varotti C
    J Dermatolog Treat; 2007; 18(3):178-83. PubMed ID: 17538808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study.
    Sharma VK; Bhari N; Gupta S; Sahni K; Khanna N; Ramam M; Sethuraman G
    Indian J Dermatol Venereol Leprol; 2016; 82(4):389-94. PubMed ID: 27279296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab.
    Leshem YA; David M; Hodak E; Waitman DA; Vardy D; Israeli M; Eskin-Schwartz M; Bergman R; Mimouni D
    Arch Dermatol Res; 2014 Jan; 306(1):67-74. PubMed ID: 23591742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood pemphigus vulgaris successfully treated with rituximab.
    Kanwar AJ; Sawatkar GU; Vinay K; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2012; 78(5):632-4. PubMed ID: 22960821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris.
    Vinay K; Kanwar AJ; Mittal A; Dogra S; Minz RW; Hashimoto T
    JAMA Dermatol; 2015 Aug; 151(8):878-82. PubMed ID: 25536513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients.
    Kim JH; Kim YH; Kim MR; Kim SC
    Br J Dermatol; 2011 Sep; 165(3):646-51. PubMed ID: 21574976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oropharyngeal pemphigus vulgaris and clinical remission: a long-term, longitudinal study.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E
    Am J Clin Dermatol; 2010; 11(2):137-45. PubMed ID: 20141235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of 19 patients with severe pemphigus: prophylactic treatment with rituximab does not appear to be beneficial.
    Gregoriou S; Giatrakou S; Theodoropoulos K; Katoulis A; Loumou P; Toumbis-Ioannou E; Papadavid E; Avgerinou G; Stavrianeas N; Rigopoulos D
    Dermatology; 2014; 228(2):158-65. PubMed ID: 24557145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.